Available now: Open-access interviews with experts on the COVID-19 pandemic: epidemiology, virus biology and possible vaccines and treatmentsView All
Dr. Amanda Proudfoot Merck Serono Geneva Research Centre, Switzerland1 Talk
Amanda Proudfoot received an Honours Degree in biochemistry from the University of Witwatersrand, Johannesburg, South Africa and a PhD in biochemistry from the University of Geneva, Switzerland. She worked as a postdoctoral fellow in the Department of Medical Biochemistry, University of Geneva before joining the Glaxo Institute for Molecular Biology,... read moreGeneva in 1988. Since 1994 she has concentrated on the chemokine family, first with Glaxo, then with Serono and now with Merck Serono. Her current research concentrates on chemokine receptor antagonists.